Difference between revisions of "Drug index"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 25: Line 25:
 
*'''2015:''' [http://jco.ascopubs.org/content/33/28/3199.full Update of ASCO Clinical Practice Guideline recommendations for the use of WBC growth factors]<ref>Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13.</ref>
 
*'''2015:''' [http://jco.ascopubs.org/content/33/28/3199.full Update of ASCO Clinical Practice Guideline recommendations for the use of WBC growth factors]<ref>Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13.</ref>
  
−
=Alphabetically=
+
=Antineoplastics=
  
 
==A==
 
==A==
Line 34: Line 34:
  
 
*[[Abarelix (Plenaxis)]]
 
*[[Abarelix (Plenaxis)]]
−
*[[Abciximab (ReoPro)]]
 
 
*[[Abemaciclib (Verzenio)]]
 
*[[Abemaciclib (Verzenio)]]
 
*[[Abexinostat (PCI-24781)]] '''in clinical trials'''
 
*[[Abexinostat (PCI-24781)]] '''in clinical trials'''
 
*[[Abiraterone (Zytiga)]]
 
*[[Abiraterone (Zytiga)]]
 
*[[Acalabrutinib (Calquence)]]
 
*[[Acalabrutinib (Calquence)]]
−
*[[Acetaminophen (Tylenol)]]
 
−
*[[Acetazolamide (Diamox)]]
 
 
*[[Aclarubicin (Aclacinomycin)]]
 
*[[Aclarubicin (Aclacinomycin)]]
 
*[[Actinium Ac 225 lintuzumab (Actimab-A)]] '''in clinical trials'''
 
*[[Actinium Ac 225 lintuzumab (Actimab-A)]] '''in clinical trials'''
−
*[[Acyclovir (Zovirax)]]
 
 
*[[Adenovirus-interferon-γ (TG1042)]] '''in clinical trials'''
 
*[[Adenovirus-interferon-γ (TG1042)]] '''in clinical trials'''
 
*[[Ado-trastuzumab emtansine (Kadcyla)]]
 
*[[Ado-trastuzumab emtansine (Kadcyla)]]
Line 51: Line 47:
 
*[[Alectinib (Alecensa)]]
 
*[[Alectinib (Alecensa)]]
 
*[[Alemtuzumab (Campath)]]
 
*[[Alemtuzumab (Campath)]]
−
*[[Alendronate (Fosamax)]]
 
 
*[[Alisertib (MLN8237)]] '''in clinical trials'''
 
*[[Alisertib (MLN8237)]] '''in clinical trials'''
 
*[[Alitretinoin (Panretin)]]
 
*[[Alitretinoin (Panretin)]]
 
*[[All-trans retinoic acid (ATRA)]]
 
*[[All-trans retinoic acid (ATRA)]]
−
*[[Allopurinol (Zyloprim)]]
+
*[[Alpelisib (Piqray)]]
−
*[[Alpelisib (Piqray)]] '''FDA approved 5/24/2019'''
 
−
*[[Alprazolam (Xanax)]]
 
 
*[[Altretamine (Hexalen)]]
 
*[[Altretamine (Hexalen)]]
 
*[[Alvocidib (Flavopiridol)]]
 
*[[Alvocidib (Flavopiridol)]]
Line 63: Line 56:
 
*[[AMG 330]] '''in clinical trials'''
 
*[[AMG 330]] '''in clinical trials'''
 
*[[Amifostine (Ethyol)]]
 
*[[Amifostine (Ethyol)]]
−
*[[Aminocaproic acid (Amicar)]]
 
 
*[[Aminoglutethimide (Cytadren)]]
 
*[[Aminoglutethimide (Cytadren)]]
−
*[[Aminopterin]]
+
*[[Aminopterin]] '''discontinued'''
 
*[[Amonafide (Quinamed)]] '''in clinical trials'''
 
*[[Amonafide (Quinamed)]] '''in clinical trials'''
−
*[[Amoxicillin]]
 
 
*[[Amrubicin (Calsed)]]
 
*[[Amrubicin (Calsed)]]
 
*[[Amsacrine (Amsidine)]]
 
*[[Amsacrine (Amsidine)]]
−
*[[Anagrelide (Agrylin)]]
 
 
*[[Anastrozole (Arimidex)]]
 
*[[Anastrozole (Arimidex)]]
 
*[[Ancestim (Stemgen)]]
 
*[[Ancestim (Stemgen)]]
−
*[[Anti-inhibitor coagulant complex (FEIBA NF)]]
 
−
*[[Antithrombin III (human and recombinant)]]
 
−
*[[Antithymocyte globulin, horse ATG (Atgam)]]
 
−
*[[Antithymocyte globulin, rabbit ATG (Grafalon)]]
 
−
*[[Antithymocyte globulin, rabbit ATG (Thymoglobulin)]]
 
 
*[[Apalutamide (Erleada)]]
 
*[[Apalutamide (Erleada)]]
 
*[[Apatinib (Aitan)]]
 
*[[Apatinib (Aitan)]]
−
*[[Apixaban (Eliquis)]]
 
 
*[[Apocept (APG101)]] '''in clinical trials'''
 
*[[Apocept (APG101)]] '''in clinical trials'''
−
*[[Aprepitant (Emend)]]
 
−
*[[Argatroban (Acova)]]
 
 
*[[Arsenic trioxide (Trisenox)]]
 
*[[Arsenic trioxide (Trisenox)]]
 
*[[Asciminib (ABL001)]] '''in clinical trials'''
 
*[[Asciminib (ABL001)]] '''in clinical trials'''
−
*[[Ascorbic acid (Vitamin C)]]
 
 
*[[Asparaginase (Elspar)]] '''discontinued'''
 
*[[Asparaginase (Elspar)]] '''discontinued'''
 
*[[Asparaginase Erwinia chrysanthemi (Erwinaze)]]
 
*[[Asparaginase Erwinia chrysanthemi (Erwinaze)]]
−
*[[Aspirin]]
 
−
*[[Aspirin and dipyridamole (Aggrenox)]]
 
 
*[[Astuprotimut-R (GSK1572932A)]] '''in clinical trials'''
 
*[[Astuprotimut-R (GSK1572932A)]] '''in clinical trials'''
 
*[[Atezolizumab (Tecentriq)]]
 
*[[Atezolizumab (Tecentriq)]]
−
*[[Atropine (Atropen)]]
 
−
*[[Atovaquone (Mepron)]]
 
 
*[[Avapritinib (Ayvakit)]] '''FDA approved 1/9/2020'''
 
*[[Avapritinib (Ayvakit)]] '''FDA approved 1/9/2020'''
−
*[[Avatrombopag (Doptelet)]]
 
 
*[[Avelumab (Bavencio)]]
 
*[[Avelumab (Bavencio)]]
 
*[[Axicabtagene ciloleucel (Yescarta)]]
 
*[[Axicabtagene ciloleucel (Yescarta)]]
Line 119: Line 95:
 
*[[Bendamustine]]
 
*[[Bendamustine]]
 
*[[Benralizumab (Fasenra)]]
 
*[[Benralizumab (Fasenra)]]
−
*[[Betrixaban (Bevyxxa)]]
 
 
*[[Bevacizumab (Avastin)]]
 
*[[Bevacizumab (Avastin)]]
−
*[[Bevacizumab-awwb (Mvasi)]]
+
**[[Bevacizumab-awwb (Mvasi)]]
−
*[[Bevacizumab-bvzr (Zirabev)]]
+
**[[Bevacizumab-bvzr (Zirabev)]]
 
*[[Bexarotene (Targretin)]]
 
*[[Bexarotene (Targretin)]]
 
*[[Bicalutamide (Casodex)]]
 
*[[Bicalutamide (Casodex)]]
 
*[[Binimetinib  (MEK162)]] '''in clinical trials'''
 
*[[Binimetinib  (MEK162)]] '''in clinical trials'''
−
*[[Bivalirudin (Angiomax)]]
 
 
*[[BHQ880]] '''in clinical trials'''
 
*[[BHQ880]] '''in clinical trials'''
 
*[[BL22 immunotoxin (CAT-3888)]] '''in clinical trials'''
 
*[[BL22 immunotoxin (CAT-3888)]] '''in clinical trials'''
Line 150: Line 124:
 
*[[Cabozantinib (Cometriq)]]
 
*[[Cabozantinib (Cometriq)]]
 
*[[Calaspargase (Asparlas)]]
 
*[[Calaspargase (Asparlas)]]
−
*[[Calcium phosphate rinse (Caphosol)]]
 
−
*[[Cangrelor (Kengreal)]]
 
 
*[[Capecitabine (Xeloda)]]
 
*[[Capecitabine (Xeloda)]]
 
*[[Capivasertib (AZD5363)]] '''in clinical trials'''
 
*[[Capivasertib (AZD5363)]] '''in clinical trials'''
−
*[[Caplacizumab (Cablivi)]] '''FDA approved 1/6/2019'''
+
*[[Caplacizumab (Cablivi)]]
 
*[[Capmatinib (Tabrecta)]] '''FDA approved 5/6/2020'''
 
*[[Capmatinib (Tabrecta)]] '''FDA approved 5/6/2020'''
 
*[[Carboplatin (Paraplatin)]]
 
*[[Carboplatin (Paraplatin)]]
Line 165: Line 137:
 
*[[Cemiplimab (Libtayo)]]
 
*[[Cemiplimab (Libtayo)]]
 
*[[Ceritinib (Zykadia)]]
 
*[[Ceritinib (Zykadia)]]
−
*[[Cetirizine (Zyrtec)]]
 
 
*[[Cetuximab (Erbitux)]]
 
*[[Cetuximab (Erbitux)]]
 
*[[Chidamide (Epidaza)]]
 
*[[Chidamide (Epidaza)]]
 
*[[Chlorambucil (Leukeran)]]
 
*[[Chlorambucil (Leukeran)]]
 
*[[Chlorozotocin (DCNU)]]
 
*[[Chlorozotocin (DCNU)]]
−
*[[Chlorpheniramine (Chlor-Trimeton)]]
 
−
*[[Cilostazol (Pletal)]]
 
−
*[[Cimetidine (Tagamet)]]
 
−
*[[Ciprofloxacin (Cipro)]]
 
 
*[[Cisplatin (Platinol)]]
 
*[[Cisplatin (Platinol)]]
 
*[[Cixutumumab (IMC-A12)]] '''in clinical trials'''
 
*[[Cixutumumab (IMC-A12)]] '''in clinical trials'''
 
*[[Cladribine (Leustatin)]]
 
*[[Cladribine (Leustatin)]]
−
*[[Clarithromycin (Biaxin)]]
 
−
*[[Clemastine (Tavist)]]
 
−
*[[Clodronate (Bonefos)]]
 
 
*[[Clofarabine (Clolar)]]
 
*[[Clofarabine (Clolar)]]
−
*[[Clopidogrel (Plavix)]]
 
 
*[[Cobimetinib (Cotellic)]]
 
*[[Cobimetinib (Cotellic)]]
 
*[[Coltuximab ravtansine (CoR, SAR3419)]] '''in clinical trials'''
 
*[[Coltuximab ravtansine (CoR, SAR3419)]] '''in clinical trials'''
Line 187: Line 150:
 
*[[Cortisone]]
 
*[[Cortisone]]
 
*[[Crenolanib (CP-868,596)]] '''in clinical trials'''
 
*[[Crenolanib (CP-868,596)]] '''in clinical trials'''
−
*[[Crizanlizumab (Adakveo)]] '''FDA approved 11/15/2019'''
 
 
*[[Crizotinib (Xalkori)]]
 
*[[Crizotinib (Xalkori)]]
 
*[[Custirsen (OGX-011)]] '''in clinical trials'''
 
*[[Custirsen (OGX-011)]] '''in clinical trials'''
−
*[[Cyanocobalamin (Vitamin B12)]]
 
 
*[[Cyclophosphamide (Cytoxan)]]
 
*[[Cyclophosphamide (Cytoxan)]]
−
*[[Cyclosporine modified (Neoral)]]
 
−
*[[Cyclosporine non-modified (Sandimmune)]]
 
 
*[[Cyproterone acetate (Androcur)]]
 
*[[Cyproterone acetate (Androcur)]]
 
*[[Cytarabine (Ara-C)]]
 
*[[Cytarabine (Ara-C)]]
 
*[[Cytarabine and daunorubicin liposomal (Vyxeos)]]
 
*[[Cytarabine and daunorubicin liposomal (Vyxeos)]]
 
*[[Cytarabine liposomal (DepoCyt)]]
 
*[[Cytarabine liposomal (DepoCyt)]]
−
*[[Cytomegalovirus Immune Globulin (Cytogam)]]
 
  
 
==D==
 
==D==
Line 206: Line 164:
 
|}
 
|}
  
−
*[[Dabigatran (Pradaxa)]]
 
 
*[[Dabrafenib (Tafinlar)]]
 
*[[Dabrafenib (Tafinlar)]]
 
*[[Dacarbazine (DTIC)]]
 
*[[Dacarbazine (DTIC)]]
 
*[[Dacomitinib (Vizimpro)]]
 
*[[Dacomitinib (Vizimpro)]]
 
*[[Dactinomycin (Cosmegen)]]
 
*[[Dactinomycin (Cosmegen)]]
−
*[[Dalteparin (Fragmin)]]
 
−
*[[Danazol (Danocrine)]]
 
−
*[[Dapsone (Aczone)]]
 
 
*[[Daratumumab (Darzalex)]]
 
*[[Daratumumab (Darzalex)]]
 
*[[Daratumumab and hyaluronidase (Darzalex Faspro)]] '''FDA approved 5/1/2020'''
 
*[[Daratumumab and hyaluronidase (Darzalex Faspro)]] '''FDA approved 5/1/2020'''
−
*[[Darbepoetin alfa (Aranesp)]]
+
*[[Darolutamide (Nubeqa)]]
−
*[[Darolutamide (Nubeqa)]] '''FDA approved 7/30/2019'''
 
 
*[[Dasatinib (Sprycel)]]
 
*[[Dasatinib (Sprycel)]]
 
*[[Daunorubicin (Cerubidine)]]
 
*[[Daunorubicin (Cerubidine)]]
Line 223: Line 176:
 
*[[Decitabine (Dacogen)]]
 
*[[Decitabine (Dacogen)]]
 
*[[Decitabine and cedazuridine (Inqovi)]] '''FDA approved 7/7/2020'''
 
*[[Decitabine and cedazuridine (Inqovi)]] '''FDA approved 7/7/2020'''
−
*[[Deferasirox (Exjade)]]
 
−
*[[Deferasirox (Jadenu)]]
 
−
*[[Deferiprone (Ferriprox)]]
 
−
*[[Deferoxamine (Desferal)]]
 
−
*[[Defibrotide (Defitelio)]]
 
 
*[[Degarelix (Firmagon)]]
 
*[[Degarelix (Firmagon)]]
 
*[[Denileukin diftitox (Ontak)]]
 
*[[Denileukin diftitox (Ontak)]]
 
*[[Denintuzumab mafodotin (SGN-CD19A)]] '''in clinical trials'''
 
*[[Denintuzumab mafodotin (SGN-CD19A)]] '''in clinical trials'''
−
*[[Denosumab (Xgeva)]]
 
−
*[[Desmopressin (DDAVP)]]
 
 
*[[Dexamethasone (Decadron)]]
 
*[[Dexamethasone (Decadron)]]
−
*[[Dexchlorpheniramine (Polaramine)]]
 
−
*[[Dexrazoxane (Zinecard)]]
 
 
*[[Diethylstilbestrol (DES)]]
 
*[[Diethylstilbestrol (DES)]]
 
*[[Dinaciclib (SCH 727965)]] '''in clinical trials'''
 
*[[Dinaciclib (SCH 727965)]] '''in clinical trials'''
 
*[[Dinutuximab (Unituxin)]]
 
*[[Dinutuximab (Unituxin)]]
−
*[[Diphenhydramine (Benadryl)]]
 
−
*[[Dipyridamole (Persantine)]]
 
 
*[[Discodermolide (XAA296)]] '''in clinical trials'''
 
*[[Discodermolide (XAA296)]] '''in clinical trials'''
 
*[[DMUC5754A]] '''in clinical trials'''
 
*[[DMUC5754A]] '''in clinical trials'''
 
*[[Docetaxel (Taxotere)]]
 
*[[Docetaxel (Taxotere)]]
−
*[[Docusate (Colace)]]
 
−
*[[Dolasetron (Anzemet)]]
 
−
*[[Domperidone (Motilium)]]
 
 
*[[Dovitinib (TKI-258)]] '''in clinical trials'''
 
*[[Dovitinib (TKI-258)]] '''in clinical trials'''
 
*[[Doxifluridine (Didox)]]
 
*[[Doxifluridine (Didox)]]
 
*[[Doxorubicin (Adriamycin)]]
 
*[[Doxorubicin (Adriamycin)]]
 
*[[Pegylated liposomal doxorubicin (Doxil)]]
 
*[[Pegylated liposomal doxorubicin (Doxil)]]
−
*[[Doxycycline]]
 
−
*[[Dronabinol (Marinol)]]
 
 
*[[Durvalumab (Imfinzi)]]
 
*[[Durvalumab (Imfinzi)]]
 
*[[Dutasteride (Avodart)]]
 
*[[Dutasteride (Avodart)]]
Line 263: Line 200:
 
|}
 
|}
  
−
*[[Eculizumab (Soliris)]]
+
*[[Edrecolomab (Panorex)]] '''discontinued'''
−
*[[Edoxaban (Savaysa)]]
 
−
*[[Edrecolomab (Panorex)]]
 
 
*[[Elotuzumab (Empliciti)]]
 
*[[Elotuzumab (Empliciti)]]
−
*[[Eltrombopag (Promacta)]]
 
 
*[[Emapalumab (Gamifant)]]
 
*[[Emapalumab (Gamifant)]]
−
*[[Emicizumab-kxwh (Hemlibra)]]
 
 
*[[Emepepimut-S (Stimuvax)]] '''in clinical trials'''
 
*[[Emepepimut-S (Stimuvax)]] '''in clinical trials'''
 
*[[Enasidenib (Idhifa)]]
 
*[[Enasidenib (Idhifa)]]
 
*[[Encorafenib (LGX818)]] '''in clinical trials'''
 
*[[Encorafenib (LGX818)]] '''in clinical trials'''
−
*[[Enfortumab vedotin (Padcev)]] '''FDA approved 12/18/2019'''
+
*[[Enfortumab vedotin (Padcev)]]
−
*[[Enoxaparin (Lovenox)]]
 
 
*[[Ensartinib (X-396)]] '''in clinical trials'''
 
*[[Ensartinib (X-396)]] '''in clinical trials'''
 
*[[Entinostat (SNDX-275)]] '''in clinical trials'''
 
*[[Entinostat (SNDX-275)]] '''in clinical trials'''
 
*[[Entospletinib (GS-9973)]] '''in clinical trials'''
 
*[[Entospletinib (GS-9973)]] '''in clinical trials'''
−
*[[Entrectinib (Rozlytrek)]] '''FDA approved 8/15/2019'''
+
*[[Entrectinib (Rozlytrek)]]
 
*[[Enzalutamide (Xtandi)]]
 
*[[Enzalutamide (Xtandi)]]
 
*[[Epirubicin (Ellence)]]
 
*[[Epirubicin (Ellence)]]
−
*[[Epoetin alfa (Procrit)]]
 
−
*[[Epoetin alfa-epbx (Retacrit)]]
 
 
*[[Epratuzumab (LymphoCide)]] '''in clinical trials'''
 
*[[Epratuzumab (LymphoCide)]] '''in clinical trials'''
−
*[[Eptifibatide (Integrilin)]]
+
*[[Erdafitinib (Balversa)]]
−
*[[Erdafitinib (Balversa)]] '''FDA approved 4/12/2019'''
 
 
*[[Eribulin (Halaven)]]
 
*[[Eribulin (Halaven)]]
 
*[[Erlotinib (Tarceva)]]
 
*[[Erlotinib (Tarceva)]]
Line 301: Line 230:
 
|}
 
|}
  
−
*[[Factor VIIa, recombinant (NovoSeven RT)]]
+
*[[Fam-trastuzumab deruxtecan (Enhertu)]]
−
*[[Factor VIII, human]]
+
*[[Fedratinib (Inrebic)]]
−
*[[Factor VIII, recombinant]]
 
−
*[[Factor IX, human]]
 
−
*[[Factor IX, recombinant]]
 
−
*[[Factor IX, recombinant, Fc fusion protein (Alprolix)]]
 
−
*[[Factor X, human (Coagadex)]]
 
−
*[[Factor Xa, recombinant, inactivated-zhzo (Andexxa)]]
 
−
*[[Factor XIII concentrate, human (Corifact)]]
 
−
*[[Famciclovir (Famvir)]]
 
−
*[[Famotidine (Pepcid)]]
 
−
*[[Fam-trastuzumab deruxtecan (Enhertu)]] '''FDA approved 12/20/2019'''
 
−
*[[Fedratinib (Inrebic)]] '''FDA approved 8/16/2019'''
 
−
*[[Ferric carboxymaltose (Injectafer)]]
 
−
*[[Ferric gluconate (Ferrlecit)]]
 
−
*[[Ferrous sulfate (Feosol)]]
 
−
*[[Ferumoxytol (Feraheme)]]
 
−
*[[Fibrinogen concentrate, human (RiaSTAP)]]
 
 
*[[Filanesib (ARRY-520)]] '''in clinical trials'''
 
*[[Filanesib (ARRY-520)]] '''in clinical trials'''
−
*[[Filgrastim (Neupogen)]]
 
−
*[[Filgrastim-aafi (Nivestym)]]
 
−
*[[Filgrastim-sndz (Zarxio)]]
 
−
*[[Finasteride (Proscar)]]
 
 
*[[Fluorouracil (5-FU)]]
 
*[[Fluorouracil (5-FU)]]
 
*[[Floxuridine (FUDR)]]
 
*[[Floxuridine (FUDR)]]
−
*[[Fluconazole (Diflucan)]]
 
 
*[[Fludarabine (Fludara)]]
 
*[[Fludarabine (Fludara)]]
 
*[[Fluoxymesterone (Halotestin)]]
 
*[[Fluoxymesterone (Halotestin)]]
 
*[[Flutamide (Eulexin)]]
 
*[[Flutamide (Eulexin)]]
−
*[[Folic acid (Folate)]]
 
 
*[[Folinic acid (Leucovorin)]]
 
*[[Folinic acid (Leucovorin)]]
−
*[[Fondaparinux (Arixtra)]]
 
 
*[[Formestane (Lentaron)]]
 
*[[Formestane (Lentaron)]]
 
*[[Forodesine (Fodosine)]] '''in clinical trials'''
 
*[[Forodesine (Fodosine)]] '''in clinical trials'''
−
*[[Fosaprepitant (Emend for Injection)]]
 
 
*[[Fostamatinib (Tavalisse)]]
 
*[[Fostamatinib (Tavalisse)]]
 
*[[Fotemustine (Muphoran)]] '''in clinical trials'''
 
*[[Fotemustine (Muphoran)]] '''in clinical trials'''
 
*[[Fruquintinib (HMPL-013)]] '''in clinical trials'''
 
*[[Fruquintinib (HMPL-013)]] '''in clinical trials'''
 
*[[Fulvestrant (Faslodex)]]
 
*[[Fulvestrant (Faslodex)]]
−
*[[Furosemide (Lasix)]]
 
 
*[[Futibatinib (TAS-120)]] '''in clinical trials'''
 
*[[Futibatinib (TAS-120)]] '''in clinical trials'''
  
Line 356: Line 260:
 
*[[Gemcitabine (Gemzar)]]
 
*[[Gemcitabine (Gemzar)]]
 
*[[Gemcitabine elaidate (CP-4126, CO-101)]] '''in clinical trials'''
 
*[[Gemcitabine elaidate (CP-4126, CO-101)]] '''in clinical trials'''
−
*[[Gemtuzumab ozogamicin (Mylotarg)]] '''FDA approved 9/1/17'''
+
*[[Gemtuzumab ozogamicin (Mylotarg)]]
 
*[[Gilteritinib (Xospata)]]
 
*[[Gilteritinib (Xospata)]]
 
*[[Glasdegib (Daurismo)]]
 
*[[Glasdegib (Daurismo)]]
 
*[[Glembatumumab vedotin (CDX-011)]]] '''in clinical trials'''
 
*[[Glembatumumab vedotin (CDX-011)]]] '''in clinical trials'''
−
*[[Glucarpidase (Voraxaze)]]
 
 
*[[Goserelin (Zoladex)]]
 
*[[Goserelin (Zoladex)]]
−
*[[Granisetron (Kytril)]]
 
−
*[[Granisetron (Sancuso)]]
 
−
*[[Granisetron (Sustol)]]
 
 
*[[Guadecitabine (SGI-110)]] '''in clinical trials'''
 
*[[Guadecitabine (SGI-110)]] '''in clinical trials'''
  
Line 373: Line 273:
 
|}
 
|}
  
−
*[[Haloperidol (Haldol)]]
 
−
*[[Hematopoetic progenitor cells, cord blood (Hemacord)]]
 
 
*[[Heptaplatin (Sunpla)]]
 
*[[Heptaplatin (Sunpla)]]
 
*[[HER2 peptide vaccine (AE37)]] '''in clinical trials'''
 
*[[HER2 peptide vaccine (AE37)]] '''in clinical trials'''
Line 388: Line 286:
 
|}
 
|}
  
−
*[[Ibandronate (Boniva)]]
 
 
*[[Ibritumomab tiuxetan (Zevalin)]]
 
*[[Ibritumomab tiuxetan (Zevalin)]]
 
*[[Ibrutinib (Imbruvica)]]
 
*[[Ibrutinib (Imbruvica)]]
 
*[[Icotinib (Conmana)]]
 
*[[Icotinib (Conmana)]]
 
*[[Idarubicin (Idamycin)]]
 
*[[Idarubicin (Idamycin)]]
−
*[[Idarucizumab (Praxbind)]]
 
 
*[[Idasanutlin (RG7388)]] '''in clinical trials'''
 
*[[Idasanutlin (RG7388)]] '''in clinical trials'''
 
*[[Idelalisib (Zydelig)]]
 
*[[Idelalisib (Zydelig)]]
Line 401: Line 297:
 
*[[Imetelstat (GRN163L)]] '''in clinical trials'''
 
*[[Imetelstat (GRN163L)]] '''in clinical trials'''
 
*[[Indatuximab ravtansine (BT062)]] '''in clinical trials'''
 
*[[Indatuximab ravtansine (BT062)]] '''in clinical trials'''
−
*[[Indomethacin (Indocin)]]
 
 
*[[Infigratinib (BGJ398)]] '''in clinical trials'''
 
*[[Infigratinib (BGJ398)]] '''in clinical trials'''
 
*[[Inotuzumab ozogamicin (Besponsa)]]
 
*[[Inotuzumab ozogamicin (Besponsa)]]
Line 414: Line 309:
 
*[[Irinotecan (Camptosar)]]
 
*[[Irinotecan (Camptosar)]]
 
*[[Irinotecan liposome (Onivyde)]]
 
*[[Irinotecan liposome (Onivyde)]]
−
*[[Iron dextran (INFeD)]]
 
−
*[[Iron sucrose (Venofer)]]
 
 
*[[Isatuximab (Sarclisa)]] '''FDA approved 3/2/2020'''
 
*[[Isatuximab (Sarclisa)]] '''FDA approved 3/2/2020'''
 
*[[Isotretinoin (Accutane)]]
 
*[[Isotretinoin (Accutane)]]
−
*[[Itraconazole (Sporanox)]]
 
 
*[[Ivosidenib (Tibsovo)]]
 
*[[Ivosidenib (Tibsovo)]]
 
*[[Ixabepilone (Ixempra)]]
 
*[[Ixabepilone (Ixempra)]]
Line 436: Line 328:
 
|[[#top|back to top]]
 
|[[#top|back to top]]
 
|}
 
|}
−
 
−
*[[Lactulose]]
 
−
*[[Lamivudine (Epivir)]]
 
 
*[[Lanreotide (Somatuline)]]
 
*[[Lanreotide (Somatuline)]]
−
*[[Lansoprazole (Prevacid)]]
 
 
*[[Lapatinib (Tykerb)]]
 
*[[Lapatinib (Tykerb)]]
 
*[[Lapuleucel-T (DN24-02)]] '''in clinical trials'''
 
*[[Lapuleucel-T (DN24-02)]] '''in clinical trials'''
Line 446: Line 334:
 
*[[Lasofoxifene (Fablyn)]] '''not FDA approved'''
 
*[[Lasofoxifene (Fablyn)]] '''not FDA approved'''
 
*[[Lenalidomide (Revlimid)]]
 
*[[Lenalidomide (Revlimid)]]
−
*[[Lenograstim (Granocyte)]]
 
 
*[[Lenvatinib (Lenvima)]]
 
*[[Lenvatinib (Lenvima)]]
−
*[[Lepirudin (Refludan)]] '''discontinued'''
 
 
*[[Lestaurtinib (CEP-701)]] '''in clinical trials'''
 
*[[Lestaurtinib (CEP-701)]] '''in clinical trials'''
 
*[[Letermovir (Prevymis)]]
 
*[[Letermovir (Prevymis)]]
 
*[[Letrozole (Femara)]]
 
*[[Letrozole (Femara)]]
 
*[[Leuprolide (Lupron)]]
 
*[[Leuprolide (Lupron)]]
−
*[[Levamisole (Ergamisol)]]
+
*[[Levamisole (Ergamisol)]] '''discontinued'''
−
*[[Levofloxacin (Levaquin)]]
 
 
*[[Levoleucovorin (Fusilev)]]
 
*[[Levoleucovorin (Fusilev)]]
−
*[[L-glutamine (Endari)]]
 
 
*[[Linifanib (ABT-869)]] '''in clinical trials'''
 
*[[Linifanib (ABT-869)]] '''in clinical trials'''
 
*[[Linsitinib (OSI-906)]] '''in clinical trials'''
 
*[[Linsitinib (OSI-906)]] '''in clinical trials'''
−
*[[Lipefilgrastim (XM22)]] '''in clinical trials'''
 
 
*[[Lisocabtagene maraleucel (Liso-cel)]] '''in clinical trials'''
 
*[[Lisocabtagene maraleucel (Liso-cel)]] '''in clinical trials'''
 
*[[Lobaplatin (D-19466)]]
 
*[[Lobaplatin (D-19466)]]
 
*[[Lomustine (CCNU)]]
 
*[[Lomustine (CCNU)]]
−
*[[Loperamide (Imodium)]]
 
−
*[[Lorazepam (Ativan)]]
 
 
*[[Lorlatinib (Lorbrena)]]
 
*[[Lorlatinib (Lorbrena)]]
 
*[[Lorvotuzumab mertansine (BB-10901)]] '''in clinical trials'''
 
*[[Lorvotuzumab mertansine (BB-10901)]] '''in clinical trials'''
 
*[[Lurbinectedin (Zepzelca)]] '''FDA approved 6/15/2020'''
 
*[[Lurbinectedin (Zepzelca)]] '''FDA approved 6/15/2020'''
−
*[[Luspatercept (Reblozyl)]] '''FDA approved 11/8/2019'''
 
−
*[[Lusutrombopag (Mulpleta)]]
 
 
*[[Lutetium Lu 177 dotatate (Lutathera)]]
 
*[[Lutetium Lu 177 dotatate (Lutathera)]]
 
*[[LY3023414]] '''in clinical trials'''
 
*[[LY3023414]] '''in clinical trials'''
Line 478: Line 357:
 
|[[#top|back to top]]
 
|[[#top|back to top]]
 
|}
 
|}
−
 
−
*[[Mannitol]]
 
 
*[[Mapatumumab (HGS-ETR1)]] '''in clinical trials'''
 
*[[Mapatumumab (HGS-ETR1)]] '''in clinical trials'''
 
*[[Masitinib (AB1010)]] '''in clinical trials'''
 
*[[Masitinib (AB1010)]] '''in clinical trials'''
Line 486: Line 363:
 
*[[Megestrol (Megace)]]
 
*[[Megestrol (Megace)]]
 
*[[Melphalan (Alkeran)]]
 
*[[Melphalan (Alkeran)]]
−
*[[Meperidine (Demerol)]]
 
 
*[[Mepolizumab (Nucala)]]
 
*[[Mepolizumab (Nucala)]]
 
*[[Mercaptopurine (6-MP)]]
 
*[[Mercaptopurine (6-MP)]]
−
*[[Mesna (Mesnex)]]
 
 
*[[Methotrexate (MTX)]]
 
*[[Methotrexate (MTX)]]
 
*[[Methoxsalen (Uvadex)]]
 
*[[Methoxsalen (Uvadex)]]
 
*[[Methylprednisolone (Solumedrol)]]
 
*[[Methylprednisolone (Solumedrol)]]
−
*[[Methyltesterone (Android)]]
 
−
*[[Metoclopramide (Reglan)]]
 
 
*[[Midostaurin (Rydapt)]]
 
*[[Midostaurin (Rydapt)]]
 
*[[Mifamurtide (Mepact)]]
 
*[[Mifamurtide (Mepact)]]
Line 510: Line 383:
 
*[[Motesanib (AMG 706)]] '''in clinical trials'''
 
*[[Motesanib (AMG 706)]] '''in clinical trials'''
 
*[[Moxetumomab pasudotox (Lumoxiti)]]
 
*[[Moxetumomab pasudotox (Lumoxiti)]]
−
*[[Mycophenolate mofetil (CellCept)]]
 
  
 
==N==
 
==N==
Line 518: Line 390:
 
|}
 
|}
  
−
*[[Nabilone (Cesamet)]]
 
 
*[[Naxitamab-gqgk (Danyelza)]] '''FDA approved 11/24/2020'''
 
*[[Naxitamab-gqgk (Danyelza)]] '''FDA approved 11/24/2020'''
 
*[[Necitumumab (Portrazza)]]
 
*[[Necitumumab (Portrazza)]]
Line 525: Line 396:
 
*[[NEOD001]]
 
*[[NEOD001]]
 
*[[Neratinib (Nerlynx)]]
 
*[[Neratinib (Nerlynx)]]
−
*[[Netupitant and palonosetron (Akynzeo)]]
 
 
*[[Nilotinib (Tasigna)]]
 
*[[Nilotinib (Tasigna)]]
 
*[[Nilutamide (Nilandron)]]
 
*[[Nilutamide (Nilandron)]]
Line 547: Line 417:
 
*[[Octreotide LAR (Sandostatin LAR)]]
 
*[[Octreotide LAR (Sandostatin LAR)]]
 
*[[Ofatumumab (Arzerra)]]
 
*[[Ofatumumab (Arzerra)]]
−
*[[Olanzapine (Zyprexa)]]
 
 
*[[Olaparib (Lynparza)]]
 
*[[Olaparib (Lynparza)]]
 
*[[Olaptesed pegol (NOX-A12)]] '''in clinical trials'''
 
*[[Olaptesed pegol (NOX-A12)]] '''in clinical trials'''
 
*[[Olaratumab (Lartruvo)]] '''discontinued'''
 
*[[Olaratumab (Lartruvo)]] '''discontinued'''
 
*[[Omacetaxine (Synribo)]]
 
*[[Omacetaxine (Synribo)]]
−
*[[Omeprazole (Prilosec)]]
 
 
*[[Onartuzumab (MetMAb)]] '''in clinical trials'''
 
*[[Onartuzumab (MetMAb)]] '''in clinical trials'''
−
*[[Ondansetron (Zofran)]]
 
−
*[[Oprelvekin (Neumega)]]
 
 
*[[Oprozomib (ONX 0912)]] '''in clinical trials'''
 
*[[Oprozomib (ONX 0912)]] '''in clinical trials'''
 
*[[Orteronel (TAK-700)]] '''in clinical trials'''
 
*[[Orteronel (TAK-700)]] '''in clinical trials'''
Line 574: Line 440:
 
*[[Pacritinib (SB1518)]] '''in clinical trials'''
 
*[[Pacritinib (SB1518)]] '''in clinical trials'''
 
*[[Palbociclib (Ibrance)]]
 
*[[Palbociclib (Ibrance)]]
−
*[[Palifermin (Kepivance)]]
 
−
*[[Palonosetron (Aloxi)]]
 
−
*[[Pamidronate (Aredia)]]
 
 
*[[Panitumumab (Vectibix)]]
 
*[[Panitumumab (Vectibix)]]
 
*[[Panobinostat (Farydak)]]
 
*[[Panobinostat (Farydak)]]
−
*[[Pantoprazole (Protonix)]]
 
 
*[[Pazopanib (Votrient)]]
 
*[[Pazopanib (Votrient)]]
 
*[[Pegaspargase (Oncaspar)]]
 
*[[Pegaspargase (Oncaspar)]]
−
*[[Pegfilgrastim (Neulasta)]]
 
−
*[[Pegfilgrastim-bmez (Ziextenzo)]]
 
−
*[[Pegfilgrastim-cbqv (Udenyca)]]
 
−
*[[Pegfilgrastim-jmdb (Fulphila)]]
 
 
*[[Peginterferon alfa-2a (Pegasys)]]
 
*[[Peginterferon alfa-2a (Pegasys)]]
 
*[[Peginterferon alfa-2b (Sylatron)]]
 
*[[Peginterferon alfa-2b (Sylatron)]]
Line 591: Line 449:
 
*[[Pemetrexed (Alimta)]]
 
*[[Pemetrexed (Alimta)]]
 
*[[Pemigatinib (Pemazyre)]] '''FDA approved 4/17/2020'''
 
*[[Pemigatinib (Pemazyre)]] '''FDA approved 4/17/2020'''
−
*[[Penicillin V]]
 
−
*[[Pentamidine (Nebupent)]]
 
 
*[[Pentostatin (Nipent)]]
 
*[[Pentostatin (Nipent)]]
 
*[[Pentraxin 2 (PRM-151)]] '''in clinical trials'''
 
*[[Pentraxin 2 (PRM-151)]] '''in clinical trials'''
 
*[[Perifosine (KRX-0401)]] '''in clinical trials'''
 
*[[Perifosine (KRX-0401)]] '''in clinical trials'''
 
*[[Pertuzumab (Perjeta)]]
 
*[[Pertuzumab (Perjeta)]]
−
*[[Pexidartinib (Turalio)]] '''FDA approved 8/2/2019'''
+
*[[Pexidartinib (Turalio)]]
−
*[[Phenytoin (Dilantin)]]
 
 
*[[Phosphomannopentaose sulfate (PI-88)]] '''in clinical trials'''
 
*[[Phosphomannopentaose sulfate (PI-88)]] '''in clinical trials'''
−
*[[Phytonadione (Vitamin K)]]
 
 
*[[Pictilisib (GDC-0941)]] '''in clinical trials'''
 
*[[Pictilisib (GDC-0941)]] '''in clinical trials'''
 
*[[Pidilizumab (CT-011)]] '''in clinical trials'''
 
*[[Pidilizumab (CT-011)]] '''in clinical trials'''
Line 606: Line 460:
 
*[[Pirarubicin (THP)]]
 
*[[Pirarubicin (THP)]]
 
*[[Pixantrone (Pixuvri)]]
 
*[[Pixantrone (Pixuvri)]]
−
*[[Plerixafor (Mozobil)]]
 
 
*[[Plicamycin (Mithracin)]]
 
*[[Plicamycin (Mithracin)]]
 
*[[Plinabulin (NPI-2358)]] '''in clinical trials'''
 
*[[Plinabulin (NPI-2358)]] '''in clinical trials'''
−
*[[Polatuzumab vedotin (Polivy)]] '''FDA approved 6/10/2019'''
+
*[[Polatuzumab vedotin (Polivy)]]
 
*[[Pomalidomide (Pomalyst)]]
 
*[[Pomalidomide (Pomalyst)]]
 
*[[Ponatinib (Iclusig)]]
 
*[[Ponatinib (Iclusig)]]
Line 616: Line 469:
 
*[[Pralatrexate (Folotyn)]]
 
*[[Pralatrexate (Folotyn)]]
 
*[[Pralsetinib (Gavreto)]] '''FDA approved 9/4/2020'''
 
*[[Pralsetinib (Gavreto)]] '''FDA approved 9/4/2020'''
−
*[[Prasugrel (Effient)]]
 
−
*[[Pravastatin (Pravachol)]]
 
 
*[[Prednisone (Sterapred)]]
 
*[[Prednisone (Sterapred)]]
 
*[[Prednisolone (Millipred)]]
 
*[[Prednisolone (Millipred)]]
 
*[[Procarbazine (Matulane)]]
 
*[[Procarbazine (Matulane)]]
−
*[[Prochlorperazine (Compazine)]]
 
−
*[[Promethazine (Phenergan)]]
 
−
*[[Protamine sulfate]]
 
−
*[[Prothrombin Complex Concentrate, human]]
 
  
 
==Q==
 
==Q==
−
 
−
*[[Quinine (Qualaquin)]]
 
 
*[[Quisinostat (JNJ-26481585)]] '''in clinical trials'''
 
*[[Quisinostat (JNJ-26481585)]] '''in clinical trials'''
 
*[[Quizartinib (AC220)]] '''in clinical trials'''
 
*[[Quizartinib (AC220)]] '''in clinical trials'''
Line 638: Line 483:
 
|}
 
|}
  
−
*[[Rabeprazole (Aciphex)]]
 
 
*[[Radium Ra 223 (Xofigo)]]
 
*[[Radium Ra 223 (Xofigo)]]
 
*[[Radotinib (Supect)]]
 
*[[Radotinib (Supect)]]
−
*[[Raloxifene (Evista)]]
 
 
*[[Raltitrexed (Tomudex)]]
 
*[[Raltitrexed (Tomudex)]]
−
*[[Ramosetron (Iribo)]]
 
 
*[[Ramucirumab (Cyramza)]]
 
*[[Ramucirumab (Cyramza)]]
 
*[[Ranimustine (Cymerin)]]
 
*[[Ranimustine (Cymerin)]]
−
*[[Ranitidine (Zantac)]]
 
−
*[[Rasburicase (Elitek)]]
 
 
*[[Ravulizumab (Ultomiris)]]
 
*[[Ravulizumab (Ultomiris)]]
 
*[[Realgar-Indigo naturalis formulation]]
 
*[[Realgar-Indigo naturalis formulation]]
Line 655: Line 495:
 
*[[Reovirus (Reolysin)]] '''in clinical trials'''
 
*[[Reovirus (Reolysin)]] '''in clinical trials'''
 
*[[Retaspimycin (IPI-504)]] '''in clinical trials'''
 
*[[Retaspimycin (IPI-504)]] '''in clinical trials'''
−
*[[Rho(D) immune globulin (RhoGAM)]]
 
 
*[[Ribociclib (Kisqali)]]
 
*[[Ribociclib (Kisqali)]]
 
*[[Ricolinostat (ACY-1215, Rocilinostat)]] '''in clinical trials'''
 
*[[Ricolinostat (ACY-1215, Rocilinostat)]] '''in clinical trials'''
Line 661: Line 500:
 
*[[Rilotumumab (AMG 102)]] '''in clinical trials'''
 
*[[Rilotumumab (AMG 102)]] '''in clinical trials'''
 
*[[Ripretinib (Qinlock)]] '''FDA approved 5/15/2020'''
 
*[[Ripretinib (Qinlock)]] '''FDA approved 5/15/2020'''
−
*[[Risedronate (Actonel)]]
 
 
*[[Rituximab (Rituxan)]]
 
*[[Rituximab (Rituxan)]]
−
*[[Rituximab-abbs (Truxima)]]
+
**[[Rituximab-abbs (Truxima)]]
−
*[[Rituximab-pvvr (Ruxience)]] '''FDA approved 7/2019'''
+
**[[Rituximab-pvvr (Ruxience)]]
 
*[[Rituximab and hyaluronidase human (Rituximab Hycela)]]
 
*[[Rituximab and hyaluronidase human (Rituximab Hycela)]]
−
*[[Rivaroxaban (Xarelto)]]
 
 
*[[Rociletinib (CO-1686)]] '''in clinical trials'''
 
*[[Rociletinib (CO-1686)]] '''in clinical trials'''
−
*[[Rolapitant (Varubi)]]
 
 
*[[Romidepsin (Istodax)]]
 
*[[Romidepsin (Istodax)]]
−
*[[Romiplostim (Nplate)]]
 
 
*[[Ropeginterferon alfa-2b (AOP2014)]] '''in clinical trials'''
 
*[[Ropeginterferon alfa-2b (AOP2014)]] '''in clinical trials'''
 
*[[Rucaparib (Rubraca)]]
 
*[[Rucaparib (Rubraca)]]
Line 685: Line 520:
 
*[[Sapacitabine (CS-682)]] '''in clinical trials'''
 
*[[Sapacitabine (CS-682)]] '''in clinical trials'''
 
*[[Sapanisertib (MLN0128)]] '''in clinical trials'''
 
*[[Sapanisertib (MLN0128)]] '''in clinical trials'''
−
*[[Sargramostim (Leukine)]]
 
−
*[[Scopolamine (Scopoderm)]]
 
 
*[[Seliciclib (CYC202)]] '''in clinical trials'''
 
*[[Seliciclib (CYC202)]] '''in clinical trials'''
−
*[[Selinexor (Xpovio)]] '''FDA approved 7/3/2019'''
+
*[[Selinexor (Xpovio)]]
 
*[[Selpercatinib (Retevmo)]] '''FDA approved 5/8/2020'''
 
*[[Selpercatinib (Retevmo)]] '''FDA approved 5/8/2020'''
 
*[[Selumetinib (Koselugo)]] '''FDA approved 4/10/2020'''
 
*[[Selumetinib (Koselugo)]] '''FDA approved 4/10/2020'''
 
*[[Semuloparin (AVE5026)]] '''in clinical trials'''
 
*[[Semuloparin (AVE5026)]] '''in clinical trials'''
 
*[[Semustine (MeCCNU)]]
 
*[[Semustine (MeCCNU)]]
−
*[[Sennosides (Senna)]]
 
−
*[[Siltuximab (Sylvant)]]
 
 
*[[Sipuleucel-T (Provenge)]]
 
*[[Sipuleucel-T (Provenge)]]
−
*[[Sirolimus (Rapamune)]]
 
 
*[[Sonidegib (Odomzo)]]
 
*[[Sonidegib (Odomzo)]]
 
*[[Sorafenib (Nexavar)]]
 
*[[Sorafenib (Nexavar)]]
Line 714: Line 544:
  
 
*[[Tabalumab (LY2127399)]] '''in clinical trials'''
 
*[[Tabalumab (LY2127399)]] '''in clinical trials'''
−
*[[Tacrolimus (Prograf)]]
 
 
*[[Tafasitamab (Monjuvi)]] '''FDA approved 7/31/2020'''
 
*[[Tafasitamab (Monjuvi)]] '''FDA approved 7/31/2020'''
 
*[[Tagraxofusp (Elzonris)]]
 
*[[Tagraxofusp (Elzonris)]]
Line 722: Line 551:
 
*[[Tamoxifen (Nolvadex)]]
 
*[[Tamoxifen (Nolvadex)]]
 
*[[Tazemetostat (Tazverik)]] '''FDA approved 1/23/2020'''
 
*[[Tazemetostat (Tazverik)]] '''FDA approved 1/23/2020'''
−
*[[Tbo-filgrastim (Granix)]]
 
 
*[[Tegafur and uracil (UFT)]]
 
*[[Tegafur and uracil (UFT)]]
 
*[[Tegafur, gimeracil, oteracil (Teysuno, S-1)]]
 
*[[Tegafur, gimeracil, oteracil (Teysuno, S-1)]]
Line 737: Line 565:
 
*[[Thiotepa (Tepadina)]]
 
*[[Thiotepa (Tepadina)]]
 
*[[Thiotepa (Thioplex)]]
 
*[[Thiotepa (Thioplex)]]
−
*[[Ticagrelor (Brilinta)]]
 
−
*[[Ticlodipine (Ticlid)]]
 
 
*[[Tigatuzumab (CS-1008)]] '''in clinical trials'''
 
*[[Tigatuzumab (CS-1008)]] '''in clinical trials'''
−
*[[Tinzaparin (Innohep)]]
 
 
*[[Tipifarnib (Zarnestra)]] '''in clinical trials'''
 
*[[Tipifarnib (Zarnestra)]] '''in clinical trials'''
 
*[[Tirabrutinib (GS-4059)]] '''in clinical trials'''
 
*[[Tirabrutinib (GS-4059)]] '''in clinical trials'''
−
*[[Tirofiban (Aggrastat)]]
+
*[[Tisagenlecleucel (Kymriah)]]
−
*[[Tisagenlecleucel (Kymriah)]] '''FDA approved 8/30/17'''
 
 
*[[Tivantinib (ARQ 197)]] '''in clinical trials'''
 
*[[Tivantinib (ARQ 197)]] '''in clinical trials'''
 
*[[Tivozanib (AV-951)]] '''in clinical trials'''
 
*[[Tivozanib (AV-951)]] '''in clinical trials'''
−
*[[Tocilizumab (Actemra)]]
 
−
*[[Tofacitinib (Xeljanz)]]
 
 
*[[Topotecan (Hycamtin)]]
 
*[[Topotecan (Hycamtin)]]
 
*[[Toremifene (Fareston)]]
 
*[[Toremifene (Fareston)]]
Line 755: Line 577:
 
*[[Trabectedin (Yondelis)]]
 
*[[Trabectedin (Yondelis)]]
 
*[[Trametinib (Mekinist)]]
 
*[[Trametinib (Mekinist)]]
−
*[[Tranexamic acid (Cyklokapron)]]
 
 
*[[Trastuzumab (Herceptin)]]
 
*[[Trastuzumab (Herceptin)]]
−
*[[Trastuzumab-anns (Kanjinti)]] '''FDA approved 6/2019'''
+
**[[Trastuzumab-anns (Kanjinti)]]
−
*[[Trastuzumab-dkst (Ogivri)]]
+
**[[Trastuzumab-dkst (Ogivri)]]
−
*[[Trastuzumab-dttb (Ontruzant)]] '''FDA approved 1/2019'''
+
**[[Trastuzumab-dttb (Ontruzant)]]
−
*[[Trastuzumab-pkrb (Herzuma)]]
+
**[[Trastuzumab-pkrb (Herzuma)]]
−
*[[Trastuzumab-qyyp (Trazimera)]] '''FDA approved 3/2019'''
+
**[[Trastuzumab-qyyp (Trazimera)]]
−
*[[Trastuzumab and hyaluronidase (Herceptin Hylecta)]] '''FDA approved 2/28/2019'''
+
*[[Trastuzumab and hyaluronidase (Herceptin Hylecta)]]
 
*[[Trebananib (AMG 386)]] '''in clinical trials'''
 
*[[Trebananib (AMG 386)]] '''in clinical trials'''
 
*[[Tremelimumab (ticilimumab)]] '''in clinical trials'''
 
*[[Tremelimumab (ticilimumab)]] '''in clinical trials'''
Line 768: Line 589:
 
*[[Trifluridine and tipiracil (Lonsurf)]]
 
*[[Trifluridine and tipiracil (Lonsurf)]]
 
*[[Trilostane (Vetoryl)]]
 
*[[Trilostane (Vetoryl)]]
−
*[[Trimethoprim-Sulfamethoxazole (Bactrim DS)]]
 
 
*[[Trimetrexate (Neutrexin)]]
 
*[[Trimetrexate (Neutrexin)]]
 
*[[Triptorelin (Trelstar LA)]]
 
*[[Triptorelin (Trelstar LA)]]
−
*[[Tropisetron (Navoban)]]
 
 
*[[Tucatinib (Tukysa)]] '''FDA approved 4/17/2020'''
 
*[[Tucatinib (Tukysa)]] '''FDA approved 4/17/2020'''
  
Line 778: Line 597:
 
*[[Ublituximab (TG-1101)]] '''in clinical trials'''
 
*[[Ublituximab (TG-1101)]] '''in clinical trials'''
 
*[[Umbralisib (TGR-1202)]] '''in clinical trials'''
 
*[[Umbralisib (TGR-1202)]] '''in clinical trials'''
−
*[[Unfractionated heparin (UFH)]]
 
 
*[[Uracil mustard]]
 
*[[Uracil mustard]]
 
*[[Urethane]]
 
*[[Urethane]]
−
*[[Uridine triacetate (Vistogard)]]
 
  
 
==V==
 
==V==
Line 790: Line 607:
  
 
*[[Vadastuximab talirine (SGN-CD33A)]] '''in clinical trials'''
 
*[[Vadastuximab talirine (SGN-CD33A)]] '''in clinical trials'''
−
*[[Valacyclovir (Valtrex)]]
 
−
*[[Valganciclovir (Valcyte)]]
 
−
*[[Valproate (Depakote)]]
 
 
*[[Valrubicin (Valstar)]]
 
*[[Valrubicin (Valstar)]]
 
*[[Vandetanib (Caprelsa)]]
 
*[[Vandetanib (Caprelsa)]]
Line 808: Line 622:
 
*[[Vismodegib (Erivedge)]]
 
*[[Vismodegib (Erivedge)]]
 
*[[Volasertib (BI 6727)]] '''in clinical trials'''
 
*[[Volasertib (BI 6727)]] '''in clinical trials'''
 +
*[[Vorinostat (Zolinza)]]
 +
*[[Vosaroxin (SNS 595)]] '''in clinical trials'''
 +
*[[Voxelotor (Oxbryta)]]
 +
*[[Voxtalisib (XL765)]] '''in clinical trials'''
 +
 +
==Z==
 +
 +
*[[Zanubrutinib (Brukinsa)]]
 +
*[[Ziv-aflibercept (Zaltrap)]]
 +
 +
=Supportive and other medications=
 +
 +
==A==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Abciximab (ReoPro)]]
 +
*[[Acetaminophen (Tylenol)]]
 +
*[[Acetazolamide (Diamox)]]
 +
*[[Acyclovir (Zovirax)]]
 +
*[[Alendronate (Fosamax)]]
 +
*[[Allopurinol (Zyloprim)]]
 +
*[[Alprazolam (Xanax)]]
 +
*[[Aminocaproic acid (Amicar)]]
 +
*[[Amoxicillin]]
 +
*[[Anagrelide (Agrylin)]]
 +
*[[Anti-inhibitor coagulant complex (FEIBA NF)]]
 +
*[[Antithrombin III (human and recombinant)]]
 +
*[[Antithymocyte globulin, horse ATG (Atgam)]]
 +
*[[Antithymocyte globulin, rabbit ATG (Grafalon)]]
 +
*[[Antithymocyte globulin, rabbit ATG (Thymoglobulin)]]
 +
*[[Apixaban (Eliquis)]]
 +
*[[Aprepitant (Emend)]]
 +
*[[Argatroban (Acova)]]
 +
*[[Ascorbic acid (Vitamin C)]]
 +
*[[Aspirin]]
 +
*[[Aspirin and dipyridamole (Aggrenox)]]
 +
*[[Atropine (Atropen)]]
 +
*[[Atovaquone (Mepron)]]
 +
*[[Avatrombopag (Doptelet)]]
 +
 +
==B==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Betrixaban (Bevyxxa)]]
 +
*[[Bivalirudin (Angiomax)]]
 +
 +
==C==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Cangrelor (Kengreal)]]
 +
*[[Calcium phosphate rinse (Caphosol)]]
 +
*[[Cetirizine (Zyrtec)]]
 +
*[[Chlorpheniramine (Chlor-Trimeton)]]
 +
*[[Cilostazol (Pletal)]]
 +
*[[Cimetidine (Tagamet)]]
 +
*[[Ciprofloxacin (Cipro)]]
 +
*[[Clarithromycin (Biaxin)]]
 +
*[[Clemastine (Tavist)]]
 +
*[[Clodronate (Bonefos)]]
 +
*[[Clopidogrel (Plavix)]]
 +
*[[Crizanlizumab (Adakveo)]]
 +
*[[Cyanocobalamin (Vitamin B12)]]
 +
*[[Cyclosporine modified (Neoral)]]
 +
*[[Cyclosporine non-modified (Sandimmune)]]
 +
*[[Cytomegalovirus Immune Globulin (Cytogam)]]
 +
 +
==D==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Dabigatran (Pradaxa)]]
 +
*[[Dalteparin (Fragmin)]]
 +
*[[Danazol (Danocrine)]]
 +
*[[Dapsone (Aczone)]]
 +
*[[Darbepoetin alfa (Aranesp)]]
 +
*[[Deferasirox (Exjade)]]
 +
*[[Deferasirox (Jadenu)]]
 +
*[[Deferiprone (Ferriprox)]]
 +
*[[Deferoxamine (Desferal)]]
 +
*[[Defibrotide (Defitelio)]]
 +
*[[Denosumab (Xgeva)]]
 +
*[[Desmopressin (DDAVP)]]
 +
*[[Dexchlorpheniramine (Polaramine)]]
 +
*[[Dexrazoxane (Zinecard)]]
 +
*[[Diphenhydramine (Benadryl)]]
 +
*[[Dipyridamole (Persantine)]]
 +
*[[Docusate (Colace)]]
 +
*[[Dolasetron (Anzemet)]]
 +
*[[Domperidone (Motilium)]]
 +
*[[Doxycycline]]
 +
*[[Dronabinol (Marinol)]]
 +
 +
==E==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Eculizumab (Soliris)]]
 +
*[[Edoxaban (Savaysa)]]
 +
*[[Eltrombopag (Promacta)]]
 +
*[[Emicizumab-kxwh (Hemlibra)]]
 +
*[[Enoxaparin (Lovenox)]]
 +
*[[Epoetin alfa (Procrit)]]
 +
*[[Epoetin alfa-epbx (Retacrit)]]
 +
*[[Eptifibatide (Integrilin)]]
 +
 +
==F==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Factor VIIa, recombinant (NovoSeven RT)]]
 +
*[[Factor VIII, human]]
 +
*[[Factor VIII, recombinant]]
 +
*[[Factor IX, human]]
 +
*[[Factor IX, recombinant]]
 +
*[[Factor IX, recombinant, Fc fusion protein (Alprolix)]]
 +
*[[Factor X, human (Coagadex)]]
 +
*[[Factor Xa, recombinant, inactivated-zhzo (Andexxa)]]
 +
*[[Factor XIII concentrate, human (Corifact)]]
 +
*[[Famciclovir (Famvir)]]
 +
*[[Famotidine (Pepcid)]]
 +
*[[Ferric carboxymaltose (Injectafer)]]
 +
*[[Ferric gluconate (Ferrlecit)]]
 +
*[[Ferrous sulfate (Feosol)]]
 +
*[[Ferumoxytol (Feraheme)]]
 +
*[[Fibrinogen concentrate, human (RiaSTAP)]]
 +
*[[Filgrastim (Neupogen)]]
 +
**[[Filgrastim-aafi (Nivestym)]]
 +
**[[Filgrastim-sndz (Zarxio)]]
 +
*[[Finasteride (Proscar)]]
 +
*[[Fluconazole (Diflucan)]]
 +
*[[Folic acid (Folate)]]
 +
*[[Fondaparinux (Arixtra)]]
 +
*[[Fosaprepitant (Emend for Injection)]]
 +
*[[Furosemide (Lasix)]]
 +
 +
==G==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Glucarpidase (Voraxaze)]]
 +
*[[Granisetron (Kytril)]]
 +
*[[Granisetron (Sancuso)]]
 +
*[[Granisetron (Sustol)]]
 +
 +
==H==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Haloperidol (Haldol)]]
 +
*[[Hematopoetic progenitor cells, cord blood (Hemacord)]]
 +
 +
==I==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Ibandronate (Boniva)]]
 +
*[[Idarucizumab (Praxbind)]]
 +
*[[Indomethacin (Indocin)]]
 +
*[[Iron dextran (INFeD)]]
 +
*[[Iron sucrose (Venofer)]]
 +
*[[Itraconazole (Sporanox)]]
 +
 +
==L==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Lactulose]]
 +
*[[Lamivudine (Epivir)]]
 +
*[[Lansoprazole (Prevacid)]]
 +
*[[Lenograstim (Granocyte)]]
 +
*[[Lepirudin (Refludan)]] '''discontinued'''
 +
*[[Levofloxacin (Levaquin)]]
 +
*[[L-glutamine (Endari)]]
 +
*[[Lipefilgrastim (XM22)]] '''in clinical trials'''
 +
*[[Loperamide (Imodium)]]
 +
*[[Lorazepam (Ativan)]]
 +
*[[Luspatercept (Reblozyl)]]
 +
*[[Lusutrombopag (Mulpleta)]]
 +
 +
==M==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
 +
*[[Mannitol]]
 +
*[[Meperidine (Demerol)]]
 +
*[[Mesna (Mesnex)]]
 +
*[[Methyltesterone (Android)]]
 +
*[[Metoclopramide (Reglan)]]
 +
*[[Mycophenolate mofetil (CellCept)]]
 +
 +
==N==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
 +
*[[Nabilone (Cesamet)]]
 +
*[[Netupitant and palonosetron (Akynzeo)]]
 +
 +
==O==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Olanzapine (Zyprexa)]]
 +
*[[Omeprazole (Prilosec)]]
 +
*[[Ondansetron (Zofran)]]
 +
*[[Oprelvekin (Neumega)]]
 +
 +
==P==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
 +
*[[Palifermin (Kepivance)]]
 +
*[[Palonosetron (Aloxi)]]
 +
*[[Pamidronate (Aredia)]]
 +
*[[Pantoprazole (Protonix)]]
 +
*[[Pegfilgrastim (Neulasta)]]
 +
**[[Pegfilgrastim-bmez (Ziextenzo)]]
 +
**[[Pegfilgrastim-cbqv (Udenyca)]]
 +
**[[Pegfilgrastim-jmdb (Fulphila)]]
 +
*[[Penicillin V]]
 +
*[[Pentamidine (Nebupent)]]
 +
*[[Phenytoin (Dilantin)]]
 +
*[[Phytonadione (Vitamin K)]]
 +
*[[Plerixafor (Mozobil)]]
 +
*[[Prasugrel (Effient)]]
 +
*[[Pravastatin (Pravachol)]]
 +
*[[Prochlorperazine (Compazine)]]
 +
*[[Promethazine (Phenergan)]]
 +
*[[Protamine sulfate]]
 +
*[[Prothrombin Complex Concentrate, human]]
 +
 +
==Q==
 +
 +
*[[Quinine (Qualaquin)]]
 +
 +
==R==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
 +
*[[Rabeprazole (Aciphex)]]
 +
*[[Raloxifene (Evista)]]
 +
*[[Ramosetron (Iribo)]]
 +
*[[Ranitidine (Zantac)]]
 +
*[[Rasburicase (Elitek)]]
 +
*[[Rho(D) immune globulin (RhoGAM)]]
 +
*[[Risedronate (Actonel)]]
 +
*[[Rivaroxaban (Xarelto)]]
 +
*[[Rolapitant (Varubi)]]
 +
*[[Romiplostim (Nplate)]]
 +
 +
==S==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Sargramostim (Leukine)]]
 +
*[[Scopolamine (Scopoderm)]]
 +
*[[Sennosides (Senna)]]
 +
*[[Siltuximab (Sylvant)]]
 +
*[[Sirolimus (Rapamune)]]
 +
 +
==T==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Tacrolimus (Prograf)]]
 +
*[[Tbo-filgrastim (Granix)]]
 +
*[[Ticagrelor (Brilinta)]]
 +
*[[Ticlodipine (Ticlid)]]
 +
*[[Tinzaparin (Innohep)]]
 +
*[[Tirofiban (Aggrastat)]]
 +
*[[Tocilizumab (Actemra)]]
 +
*[[Tofacitinib (Xeljanz)]]
 +
*[[Tranexamic acid (Cyklokapron)]]
 +
*[[Trimethoprim-Sulfamethoxazole (Bactrim DS)]]
 +
*[[Tropisetron (Navoban)]]
 +
 +
==U==
 +
*[[Unfractionated heparin (UFH)]]
 +
*[[Uridine triacetate (Vistogard)]]
 +
 +
==V==
 +
{| class="wikitable" style="float:right; margin-left: 5px;"
 +
|-
 +
|[[#top|back to top]]
 +
|}
 +
*[[Valacyclovir (Valtrex)]]
 +
*[[Valganciclovir (Valcyte)]]
 +
*[[Valproate (Depakote)]]
 
*[[von Willebrand factor and factor VIII complex, human]]
 
*[[von Willebrand factor and factor VIII complex, human]]
 
*[[von Willebrand factor, recombinant]]
 
*[[von Willebrand factor, recombinant]]
 
*[[Vorapaxar (Zontivity)]]
 
*[[Vorapaxar (Zontivity)]]
 
*[[Voriconazole (Vfend)]]
 
*[[Voriconazole (Vfend)]]
−
*[[Vorinostat (Zolinza)]]
 
−
*[[Vosaroxin (SNS 595)]] '''in clinical trials'''
 
−
*[[Voxelotor (Oxbryta)]] '''FDA approved 11/25/2019'''
 
−
*[[Voxtalisib (XL765)]] '''in clinical trials'''
 
  
 
==W==
 
==W==
Line 826: Line 947:
  
 
==Z==
 
==Z==
−
 
−
*[[Zanubrutinib (Brukinsa)]] '''FDA approved 11/14/2019'''
 
−
*[[Ziv-aflibercept (Zaltrap)]]
 
 
*[[Zoledronic acid (Zometa)]]
 
*[[Zoledronic acid (Zometa)]]
  

Revision as of 02:18, 12 December 2020

Guidelines

back to top

Other interesting and helpful links can be found by clicking the link.

Chemotherapy safety standards

Dose adjustments

Antimicrobials

Growth factors

Antineoplastics

A

back to top

B

back to top

C

back to top

D

back to top

E

back to top

F

back to top

G

back to top

H

back to top

I

back to top

J

K

L

back to top

M

back to top

N

back to top

O

back to top

P

back to top

Q

R

back to top

S

back to top

T

back to top

U

V

back to top

Z

Supportive and other medications

A

back to top

B

back to top

C

back to top

D

back to top

E

back to top

F

back to top

G

back to top

H

back to top

I

back to top

L

back to top

M

back to top

N

back to top

O

back to top

P

back to top

Q

R

back to top

S

back to top

T

back to top

U

V

back to top

W

back to top

Z

By Category

Selecting a category here will take you to a new page listing all drugs in that category (note: drug categorization is still in process so not all of these links are active).

Drugs in a REMS program

Cytotoxic Chemotherapy

back to top

Kinase inhibitors

back to top

Endocrine therapy

back to top

Investigational and Discontinued

Biologics

back to top

Supportive Medications

back to top

Radioactive agents

Benign Hematology Medications

back to top

Hematopoietic Growth Factors

back to top

Miscellaneous

back to top

Medications by Condition

back to top

Medications by Route of Administration

back to top

Medications by Year of Approval

back to top

Interesting and Helpful Links

back to top

References

  1. ↑ Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. link to original article PubMed
  2. ↑ Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13.
  3. ↑ Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015 Oct 1;33(28):3199-212. Epub 2015 Jul 13.
  4. ↑ Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: american society of clinical oncology clinical practice guideline. J Clin Oncol. 2012 May 1;30(13):1553-61. Epub 2012 Apr 2. link to original article PubMed
  5. ↑ Mancini R, Modlin J. Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart. J Hematol Oncol Pharm. 2011;1(1):17-25. link to original article
Retrieved from "https://hemonc.org/w/index.php?title=Drug_index&oldid=46727"